Eden Names Dr Allan Godsk Larsen as Managing Director to Lead Next Growth Phase.
Eden Innovations Ltd (ASX: EDE) has announced the appointment of Dr Allan Godsk Larsen as Managing Director, signalling a strategic step as the company builds on improving commercial traction and financial stability. Dr Larsen has been closely involved with Eden for nearly a decade and has played a central role in advancing its carbon nanotube–based technologies, particularly the EdenCrete concrete admixture portfolio. Recent momentum includes increasing adoption of EdenCrete Pz7 across international markets, supported by major customer orders, continued deployment in US infrastructure projects, and expanded testing programs in India. Alongside this, Eden’s OptiBlend dual-fuel systems are experiencing rising demand in the United States, with additional opportunities developing in new regions. The company has also made substantial progress in strengthening its balance sheet through debt reduction and refinancing initiatives. With his strong technical background and global commercial experience, Dr Larsen is well positioned to guide Eden’s operations as it pursues broader international growth and long-term value creation.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au
x
Daily Dose of Buy, Sell & Hold recommendations before the market opens.
Start Your 7 Days Free Trial Now!
We use cookies to help us improve, promote, and protect our services.
By continuing to use this site, we assume you consent to this.
Read our
Privacy Policy
and
Terms & Conditions
Eden Names Dr Allan Godsk Larsen as Managing Director to Lead Next Growth Phase.
Eden Innovations Ltd (ASX: EDE) has announced the appointment of Dr Allan Godsk Larsen as Managing Director, signalling a strategic step as the company builds on improving commercial traction and financial stability. Dr Larsen has been closely involved with Eden for nearly a decade and has played a central role in advancing its carbon nanotube–based technologies, particularly the EdenCrete concrete admixture portfolio. Recent momentum includes increasing adoption of EdenCrete Pz7 across international markets, supported by major customer orders, continued deployment in US infrastructure projects, and expanded testing programs in India. Alongside this, Eden’s OptiBlend dual-fuel systems are experiencing rising demand in the United States, with additional opportunities developing in new regions. The company has also made substantial progress in strengthening its balance sheet through debt reduction and refinancing initiatives. With his strong technical background and global commercial experience, Dr Larsen is well positioned to guide Eden’s operations as it pursues broader international growth and long-term value creation.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au